GIAHC, in collaboration with the Public Health Research Institute (PHRII) at Mysuru, India, has been actively involved in raising awareness about HPV and cervical cancer elimination. Leading up to World Cancer Day, PHRII, with support from partners like JSS Academy of Higher Education and Research and sponsorship from Sun Pharma’s Corporate Social Responsibility wing, initiated a program to vaccinate 193 adolescent girls in rural Mysuru District against Human Papillomavirus (HPV), the primary cause of cervical cancer. This innovative initiative integrated vaccination with school-based community education, providing interactive sessions to schoolgirls, teachers, and parents on HPV, cervical cancer, and prevention. The girls were administered the Gardasil-9 vaccine, safeguarding them against nine high-risk HPV types. Aligned with the WHO’s Global Strategy for Cervical Cancer Elimination, the program aims for 90% vaccination coverage, 70% screening for women by ages 35 and 45, and 90% treatment for identified cervical disease by 2030. Cervical cancer, ranking as the second most common cancer in Indian women, remains a significant health challenge, underscoring the importance of initiatives like Mysuru’s in raising awareness and promoting vaccination and screening.